These functions might contribute to the poor response to VDZ in IBD patients through the following pathways: (a) NOD-NFkB signaling, (b) ulcerative colitis signaling, and (c) the PID-NFkB canonical pathway. The gene discussed is MTA2; the disease is inflammatory bowel disease.